C CLARITEV CORPORATION
| Market Cap | $296.24M |
| P/E Ratio | — |
| Forward P/E | 2.55 |
| Dividend Yield | — |
| Beta | 0.54 |
| 52W Range | $13.47 - $72.58 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Health Information Services |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Daniel Loeb Third Point LLC | 0.09% | $6.20M | 145,000 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 17 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Garis Douglas MichaelEVP&CFO | Buy | 1,300 | $17.69 | $23.00K | 16 Mar 2026 | 16 Mar 2026 |
| Kim MichaelEVP, Chief Digital Officer | Buy | 15,000 | $16.50 | $247.50K | 12 Mar 2026 | 12 Mar 2026 |
| O'Neil TaraSVP, General Counsel | Buy | 750 | $12.99 | $9.74K | 02 Mar 2026 | 02 Mar 2026 |
| Kim MichaelEVP, Chief Digital Officer | Buy | 30,000 | $14.30 | $428.95K | 27 Feb 2026 | 02 Mar 2026 |
| Dalton TravisPres., CEO & Executive Chair | Buy | 15,380 | $13.00 | $199.93K | 27 Feb 2026 | 02 Mar 2026 |
| Dalton TravisPres., CEO & Executive Chair | Buy | 5,290 | $47.23 | $249.84K | 20 Nov 2025 | 20 Nov 2025 |
| Travis DaltonPres., CEO & Executive Chair | Buy | 5,290 | $47.23 | $249.84K | 20 Nov 2025 | 20 Nov 2025 |
| Mintz William B.SVP, Chief Strategy Officer | Buy | 916 | $38.00 | $34.81K | 17 Nov 2025 | 19 Nov 2025 |
| O'Neil TaraSVP, General Counsel | Buy | 625 | $38.84 | $24.27K | 17 Nov 2025 | 18 Nov 2025 |
| Kim MichaelEVP, Chief Digital Officer | Buy | 9,600 | $38.25 | $367.20K | 17 Nov 2025 | 18 Nov 2025 |
| William B. MintzSVP, Chief Strategy Officer | Buy | 916 | $38.00 | $34.81K | 17 Nov 2025 | 19 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 3,485 | $48.67 | $169.61K | 12 Nov 2025 | 14 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 20,722 | $48.67 | $1.01M | 12 Nov 2025 | 14 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 66,997 | $48.67 | $3.26M | 12 Nov 2025 | 14 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 789,936 | $48.67 | $38.44M | 12 Nov 2025 | 14 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 264,336 | $48.67 | $12.86M | 12 Nov 2025 | 14 Nov 2025 |
| H&F Corporate Investors VIII, Ltd. | Sale | 354,524 | $48.67 | $17.25M | 12 Nov 2025 | 14 Nov 2025 |
Frequently Asked Questions
What is CTEV stock price today?
CLARITEV CORPORATION (CTEV) is currently trading at $17.46. The stock has a 52-week range of $13.47 to $72.58 and a market capitalization of $296.24M.
Is CTEV a good stock to buy in 2026?
CLARITEV CORPORATION has a P/E ratio of N/A (forward P/E: 2.6), a dividend yield of none, and 1-year performance of -12.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CTEV stock?
There have been 17 insider transactions for CTEV in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CTEV stock performed over the past year?
CLARITEV CORPORATION (CTEV) has returned -12.7% over the past 12 months. The stock traded between $13.47 and $72.58 during this period, and is currently at $17.46.
Which hedge funds own CTEV (CLARITEV CORPORATION)?
1 tracked hedge funds currently hold CTEV in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CTEV's market cap and valuation?
CLARITEV CORPORATION (CTEV) has a market capitalization of $296.24M. The trailing P/E ratio is N/A and forward P/E is 2.6. The stock is classified in the Healthcare sector.
What is CTEV's revenue and profitability?
CLARITEV CORPORATION reported revenue of $965.41M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.54.
What sector is CTEV in and who are its biggest institutional holders?
CLARITEV CORPORATION (CTEV) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.